Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research, 54613 [2018-23695]
Download as PDF
<![CDATA[
54613
Federal Register / Vol. 83, No. 210 / Tuesday, October 30, 2018 / Notices
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Sigma Aldrich
Research
ACTION:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
DEPARTMENT OF JUSTICE
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before December 31, 2018.
DATES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
SUPPLEMENTARY INFORMATION:
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
delegated to the Assistant Administrator
of the DEA Diversion Control Division
(‘‘Assistant Administrator’’) pursuant to
section 7 of 28 CFR part 0, appendix to
subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on June
14, 2018, Sigma Aldrich Research, 1–3
Strathmore Road, Natick, Massachusetts
01760–2447 applied to be registered as
a bulk manufacturer of the following
basic classes of controlled substances:
Controlled substance
Drug code
Cathinone ........................................................................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ....................................................................................................................
Lysergic acid diethylamide ..............................................................................................................................................
3,4-Methylenedioxymethamphetamine ............................................................................................................................
Dimethyltryptamine ..........................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine .............................................................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) .......................................................................................................................
Heroin ..............................................................................................................................................................................
Normorphine ....................................................................................................................................................................
Norlevorphanol ................................................................................................................................................................
Amphetamine ...................................................................................................................................................................
Nabilone ...........................................................................................................................................................................
Cocaine ............................................................................................................................................................................
Codeine ...........................................................................................................................................................................
Ecgonine ..........................................................................................................................................................................
Levorphanol .....................................................................................................................................................................
Meperidine .......................................................................................................................................................................
Methadone .......................................................................................................................................................................
Morphine ..........................................................................................................................................................................
Thebaine ..........................................................................................................................................................................
Levo-alphacetylmethadol .................................................................................................................................................
Remifentanil .....................................................................................................................................................................
Sufentanil .........................................................................................................................................................................
Carfentanil .......................................................................................................................................................................
Fentanyl ...........................................................................................................................................................................
issuance of the proposed registration on
or before November 29, 2018. Such
persons may also file a written request
for a hearing on the application on or
before November 29, 2018.
The company plans to manufacture
reference standards.
Dated: October 11, 2018.
John J. Martin,
Assistant Administrator.
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
khammond on DSK30JT082PROD with NOTICES
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Catalent CTS, LLC
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
DATES:
VerDate Sep<11>2014
17:34 Oct 29, 2018
Jkt 247001
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
[FR Doc. 2018–23695 Filed 10–29–18; 8:45 am]
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
1235
1248
7315
7405
7435
7439
7535
9200
9313
9634
1100
7379
9041
9050
9180
9220
9230
9250
9300
9333
9648
9739
9740
9743
9801
Schedule
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
SUPPLEMENTARY INFORMATION:
The Attorney General has delegated
his authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on July 17,
2018, Catalent CTS, LLC, 10245
Hickman Mills Drive, Kansas City,
E:\FR\FM\30OCN1.SGM
30OCN1
]]>Agencies
[Federal Register Volume 83, Number 210 (Tuesday, October 30, 2018)]
[Notices]
[Page 54613]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-23695]
[[Page 54613]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Sigma
Aldrich Research
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before December 31, 2018.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been delegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on June
14, 2018, Sigma Aldrich Research, 1-3 Strathmore Road, Natick,
Massachusetts 01760-2447 applied to be registered as a bulk
manufacturer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Cathinone.......................... 1235 I
Mephedrone (4-Methyl-N- 1248 I
methylcathinone).
Lysergic acid diethylamide......... 7315 I
3,4-Methylenedioxymethamphetamine.. 7405 I
Dimethyltryptamine................. 7435 I
5-Methoxy-N,N-diisopropyltryptamine 7439 I
MDPV (3,4- 7535 I
Methylenedioxypyrovalerone).
Heroin............................. 9200 I
Normorphine........................ 9313 I
Norlevorphanol..................... 9634 I
Amphetamine........................ 1100 II
Nabilone........................... 7379 II
Cocaine............................ 9041 II
Codeine............................ 9050 II
Ecgonine........................... 9180 II
Levorphanol........................ 9220 II
Meperidine......................... 9230 II
Methadone.......................... 9250 II
Morphine........................... 9300 II
Thebaine........................... 9333 II
Levo-alphacetylmethadol............ 9648 II
Remifentanil....................... 9739 II
Sufentanil......................... 9740 II
Carfentanil........................ 9743 II
Fentanyl........................... 9801 II
------------------------------------------------------------------------
The company plans to manufacture reference standards.
Dated: October 11, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-23695 Filed 10-29-18; 8:45 am]
BILLING CODE 4410-09-P
